UK gener­ics mak­er shut­ters, elim­i­nat­ing 1,000 jobs

Three gener­ic drug­mak­ers have ceased op­er­a­tions im­me­di­ate­ly, as their hold­ing com­pa­ny has en­list­ed a con­sult­ing firm to over­see the process of ad­min­is­tra­tion as 1,000 em­ploy­ees …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA